Sartorius Stedim Biotech
€208.20Change from previous close: +0.97%Absolute change: +€2.00
At a glance
- Revenue growth
- +6.74%
- 2025 vs 2024
- Net income growth
- +51.68%
- 2025 vs 2024
- Net margin
- 9.0%
- 2024: 6.3%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 7,984 | 8,256 | 7,730 | 5,065 | — |
| Current assets | 1,441 | 1,741 | 1,415 | 1,671 | — |
| Cash and equivalents | 426 | 679 | 117 | 107 | — |
| Short-term investments | 8.1 | 9.9 | 9.5 | 25.9 | — |
| Inventory | 691 | 685 | 882 | 1,025 | — |
| Net property, plant and equipment | 2,025 | 1,885 | 1,633 | 1,292 | — |
| Goodwill | 2,884 | 2,908 | 2,885 | 1,136 | — |
| Other intangible assets | 1,537 | 1,632 | 1,693 | 877 | — |
| Long-term investments | 10.3 | 16.1 | 27.5 | 18.8 | — |
| Current liabilities | 1,412 | 939 | 937 | 1,036 | — |
| Accounts payable | 278 | 310 | 259 | 250 | — |
| Long-term debt | 1,867 | 2,684 | 3,510 | 1,021 | — |
| Total debt | 2,599 | 2,870 | 3,682 | 1,136 | — |
| Total liabilities | 3,858 | 4,233 | 5,056 | 2,551 | — |
| Total equity (incl. minority) | 4,126 | 4,024 | 2,674 | 2,514 | — |
| Retained earnings | 2,647 | 2,543 | 2,389 | 2,199 | — |
| Minority interest | 35.6 | 37.2 | 35.3 | 64.9 | — |